Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Flavonoids Kill Human Pancreatic Cancer Cells

By BiotechDaily International staff writers
Posted on 26 Aug 2013
Flavonoids in celery, artichokes, and especially Mexican oregano contain flavonoids that kill human pancreatic cancer cells by enzymatic inhibition, according to a new study.

Two researchers at the University of Illinois (UIC; Chicago, IL, USA) examined the inhibitory effects of flavonoids, limonoids, phenolic acids, and ascorbic acid citrus fruit bioactive compounds on BxPC-3 and PANC-1 human pancreatic cancer cells in vitro, focusing on the antiproliferative mechanism of action of the flavonoid apigenin as related to the glycogen synthase kinase-3β (GSK-3β) nuclear factor kappa B signaling pathway.

The researchers found that apigenin inhibited the GSK-3β enzymatic pathway, leading to a decrease in the production of antiapoptotic genes in the pancreatic cancer cells, thus encouraging the cancer cells to self-destruct via apoptosis. In one of the cancer cell lines, the percentage of cells undergoing apoptosis went from 8.4% in cells that had not been treated with the flavonoid to 43.8% in cells that had been treated with a 50-micromolar dose. Treatment with the flavonoid also modified gene expression, causing upregulation of certain genes associated with pro-inflammatory cytokines such interleukin 17. The study was published on August 13, 2013, in Molecular Nutrition and Food Research.

“Apigenin alone induced cell death in two aggressive human pancreatic cancer cell lines. But we received the best results when we pretreated cancer cells with apigenin for 24 hours, then applied the chemotherapeutic drug gemcitabine for 36 hours,” said study coauthor professor Elvira de Mejia, PhD. “Pancreatic cancer patients would probably not be able to eat enough flavonoid-rich foods to raise blood plasma levels of the flavonoid to an effective level. But scientists could design drugs that would achieve those concentrations.”

“The trick seemed to be using the flavonoids as a pretreatment instead of applying them and the chemotherapeutic drug simultaneously. Even though the topic is still controversial, our study indicated that taking antioxidant supplements on the same day as chemotherapeutic drugs may negate the effect of those drugs,” added coauthor Jodee Johnson, PhD. “That happens because flavonoids can act as antioxidants. One of the ways that chemotherapeutic drugs kill cells is based on their pro-oxidant activity, meaning that flavonoids and chemotherapeutic drugs may compete with each other when they're introduced at the same time.”

Flavonoids are a class of plant secondary metabolites that may modify allergens, viruses, and carcinogens, and demonstrate significant antioxidant activity in vitro that may be stronger than those of vitamin C and E. However, inside the human body, they have little or no direct antioxidant value, since flavonoids are poorly absorbed (less than 5%), with most of what is absorbed being quickly metabolized and excreted.

Related Links:

University of Illinois




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A scheme for the generation of induced pluripotent stem cells (IPSC). (1) Isolate and culture donor cells. (2) Transfect stem cell-associated genes into the cells by viral vectors. Red cells indicate the cells expressing the exogenous genes. (3)  Harvest and culture the cells using mitotically inactivated feeder cells. (4) A small subset of the transfected cells forms iPSC cell colonies (Photo courtesy of Wikimedia Commons).

Innovative Technique Produces More Reliable Pluripotent Stem Cells

A recent paper described a more reliable way to induce the formation of pluripotent stem cells (iPSCs) from adult cells in a mouse model. Reliable high-quality iPSCs are needed for the development of... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.